O-GlcNAc modification on IRS-1 and Akt2 by PUGNAc inhibits their phosphorylation and induces insulin resistance in rat primary adipocytes - PubMed (original) (raw)
. 2005 Jun 30;37(3):220-9.
doi: 10.1038/emm.2005.30.
Affiliations
- PMID: 16000877
- DOI: 10.1038/emm.2005.30
O-GlcNAc modification on IRS-1 and Akt2 by PUGNAc inhibits their phosphorylation and induces insulin resistance in rat primary adipocytes
Seung Yoon Park et al. Exp Mol Med. 2005.
Abstract
It has been known that O-linked beta-N-acetylglucosamine (O-GlcNAc) modification of proteins plays an important role in transcription, translation, nuclear transport and signal transduction. The increased flux of glucose through the hexosamine biosynthetic pathway (HBP) and increased O-GlcNAc modification of protein have been suggested as one of the causes in the development of insulin resistance. However, it is not clear at the molecular level, how O-GlcNAc protein modification results in substantial impairment of insulin signaling. To clarify the association of O-GlcNAc protein modification and insulin resistance in rat primary adipocytes, we treated the adipocytes with O-(2-acetamido-2deoxy-D-glucopyranosylidene)amino-N-phenylcarbamate (PUGNAc), a potent inhibitor of O-GlcNAcase that catalyzes removal of O-GlcNAc from proteins. Prolonged treatment of PUGNAc (100 microM for 12 h) increased O-GlcNAc modification on proteins in adipocytes. PUGNAc also drastically decreased insulin-stimulated 2-deoxyglucose (2DG) uptake and GLUT4 translocation in adipocytes, indicating that PUGNAc developed impaired glucose utilization and insulin resistance in adipocytes. Interestingly, the O-GlcNAc modification of IRS-1 and Akt2 was increased by PUGNAc, accompanied by a partial reduction of insulin-stimulated phosphorylations of IRS-1 and Akt2. The PUGNAc treatment has no effect on the expression level of GLUT4, whereas O-GlcNAc modification of GLUT4 was increased. These results suggest that the increase of O-GlcNAc modification on insulin signal pathway intermediates, such as IRS-1 and Akt2, reduces the insulin-stimulated phosphorylation of IRS-1 and Akt2, subsequently leading to insulin resistance in rat primary adipocytes.
Similar articles
- Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes.
Vosseller K, Wells L, Lane MD, Hart GW. Vosseller K, et al. Proc Natl Acad Sci U S A. 2002 Apr 16;99(8):5313-8. doi: 10.1073/pnas.072072399. Proc Natl Acad Sci U S A. 2002. PMID: 11959983 Free PMC article. - Prolonged incubation in PUGNAc results in increased protein O-Linked glycosylation and insulin resistance in rat skeletal muscle.
Arias EB, Kim J, Cartee GD. Arias EB, et al. Diabetes. 2004 Apr;53(4):921-30. doi: 10.2337/diabetes.53.4.921. Diabetes. 2004. PMID: 15047606 - O-GlcNAc modification of nucleocytoplasmic proteins and diabetes.
Akimoto Y, Hart GW, Hirano H, Kawakami H. Akimoto Y, et al. Med Mol Morphol. 2005 Jun;38(2):84-91. doi: 10.1007/s00795-004-0264-1. Med Mol Morphol. 2005. PMID: 15944815 Review. - Role of O-GlcNAcylation in nutritional sensing, insulin resistance and in mediating the benefits of exercise.
Myslicki JP, Belke DD, Shearer J. Myslicki JP, et al. Appl Physiol Nutr Metab. 2014 Nov;39(11):1205-13. doi: 10.1139/apnm-2014-0122. Epub 2014 Jul 28. Appl Physiol Nutr Metab. 2014. PMID: 25203141 Review.
Cited by
- Depletion of mitochondrial DNA stabilizes C1qTNF-related protein 6 mRNA in muscle cells.
Kim MJ, Lee W, Park EJ, Park SY. Kim MJ, et al. J Korean Med Sci. 2012 May;27(5):465-70. doi: 10.3346/jkms.2012.27.5.465. Epub 2012 Apr 25. J Korean Med Sci. 2012. PMID: 22563208 Free PMC article. - Endothelial Dysfunction in Obesity and Therapeutic Targets.
Engin A. Engin A. Adv Exp Med Biol. 2024;1460:489-538. doi: 10.1007/978-3-031-63657-8_17. Adv Exp Med Biol. 2024. PMID: 39287863 Review. - Akt1 is dynamically modified with O-GlcNAc following treatments with PUGNAc and insulin-like growth factor-1.
Gandy JC, Rountree AE, Bijur GN. Gandy JC, et al. FEBS Lett. 2006 May 29;580(13):3051-8. doi: 10.1016/j.febslet.2006.04.051. Epub 2006 Apr 27. FEBS Lett. 2006. PMID: 16684529 Free PMC article. - Multiple tissue-specific roles for the O-GlcNAc post-translational modification in the induction of and complications arising from type II diabetes.
Vaidyanathan K, Wells L. Vaidyanathan K, et al. J Biol Chem. 2014 Dec 12;289(50):34466-71. doi: 10.1074/jbc.R114.591560. Epub 2014 Oct 21. J Biol Chem. 2014. PMID: 25336652 Free PMC article. Review. - Quantitative secretome and glycome of primary human adipocytes during insulin resistance.
Lim JM, Wollaston-Hayden EE, Teo CF, Hausman D, Wells L. Lim JM, et al. Clin Proteomics. 2014 May 12;11(1):20. doi: 10.1186/1559-0275-11-20. eCollection 2014. Clin Proteomics. 2014. PMID: 24948903 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Molecular Biology Databases
Miscellaneous